The case presentation details a 47-year-old female patient diagnosed with costochondritis and systemic hypertension, presenting with chest pain radiating to the back. Initial investigations revealed signs of unstable angina, but the final diagnosis confirmed costochondritis, prompting a comprehensive treatment plan including analgesics and anti-hypertensives. Patient counseling emphasized lifestyle modifications and pain management strategies.

1. CASE PRESENTATION ON
COSTOCHONDRITIS
Vineeth Vidhyasagar. P,
I17060036,
5th Pharm.D,
Department of Pharmacy, AU.

2. C/O:
 Patient bought to causality with C/O chest pain for 2 days
 Radiating to back , both sides.
 Compressive in nature.
 No H/O breathlessness/ palpitation/ giddiness/ set vomiting/ diarrhea
 K/C/O SHTN & Angina, Cag Done @ 6months back
O/E:
 Patient conscious, oriented, afebrile.
 No P-/ I-/ C-/ C-/ L-
 BP – 130/80 mm/Hg
 PR- 74 / Min
 SpO2 – 98% @ RA
 RR- 18/min
 Name: Ambika Ward: Medicine
 Age : 47 years Unit: M1/22
 Sex : Female IP.No: 895804

3. S/E:
 CVS- S1 S2 +
 RS – B/L AE +
 NVBS +
 CNS – NFND
 P/A – Soft, BS +
INVESTIGATION:
1) CBC:
Hb-11.6g/dl
TC – 10800 Cells/cu.mm
Plt – 3.83 Lakhs Cells/cu.mm
2) ESR 7mm
5mm
3) RBS- 101 mg/dl
4)RFT:
S.Urea – 21 mg/dl
S.Creatinine – 0.8 mg/dl
5) S.Electrolytes:
S.Na+ – 141 mmol/L
S.K+ – 4 mmol/L
S.Cl- – 101 mmol/L
6) LFT:
Bilirubin (T) - 0.9 mg/dl
(P) - 0.2 mg/dl
(L) – 0.6 mg/dl
SGOT : 29 U/L
SGPT : 21 U/L
ALP : 89 U/L
7) S.Proteins:
S.Alb – 3.5 gm/dl
T.Protein – 6.7 gm/dl
S.Globulin – 3.2 gm/dl
8) CXR – PA view
9) 2D Echo :
- concentric LVH
- Grade I systolic dysfunction
- Adequate LV systolic Function
- No resulting RWHA
- No significant pain

4. TREATMENT :
1. T.Aspirin – 325 mg Stat
2. T. Clopidogrel 300 mg Stat
3. T.Atorvas 80 mg Stat
4. Inj.Heparin 5000 U IV stat
5. T.Envas 5 mg (1-0-1)
6. Syp. Creamaftin 15 ml HS
PROVISIONAL DIAGNOSIS :
1)ACS – Unstable Angina
2)Systemic Hypertension
FINAL DIAGNOSIS :
1) Costochondritis
2)Systemic Hypertension
7. T.Clonazepam 0.25 mg (0-0-1)
8. T.ISDN 2.5 mg stat
9. T.Ultracet (0-0-1)
10. Inj. Emeset 4mg IV BD
11. Inj.PAN 40 mg IV BD
12. T.Zerodol P (1-0-1)
13. T.Myospar Forte (1-0-1)

5. SOAP ANALYSIS
SUBJECTIVE:
 Patient bought to causality with C/O chest pain for 2 days
 Radiating to back , both sides.
 Compressive in nature.
 K/C/O SHTN & Angina
OBJECTIVE:
ECG – V1V2 T.Wave , III avf T.wave 
2D Echo :
concentric LVH
Grade I systolic dysfunction
Adequate LV systolic Function
No resulting RWHA
No significant pain

6. ASSESMENT :
Based on the lab investigations and the patient’s complaints it is confirmed that the patient is having
“COSTOCHONDRITIS”
PLAN
BRAND NAME GENERIC NAME CATEGORY DOSE R.O.A FREQU
ENCY
T.Aspirin Aspirin Anti-coagulant 325 mg PO OD
T.Clopidogrel Clopidogrel Anti-platelet 300 mg PO OD
T.Atorvastatin Atorvastatin Statins 80 mg PO OD
Inj.Heparin stat Heparin Anti-coagulant 5000 U IV OD

7. BRAND NAME GENERIC NAME CATEGORY DOSE R.O.A FREQU
ENCY
T.Clonazepam Clonazepam CNS Depressant 0.25 mg PO OD
Syp.magnesium
hydroxide
Mg.hydroxide Laxative 15 ml PO OD
T.Isosorbide dinitrate T.Isosorbide dinitrate Nitrates 2.5 mg PO OD
T.Tramadol Tramadol Analgesics 25 mg PO BD
Inj.pantoprazole Pantoprazole Proton pump inhibitor 40 mg IV OD
Inj. Ondansatron Ondansatron Anti emetic 4 mg IV BD
T.Aceclofenac Aceclofenac Analgesics 200 mg PO BD
T.Clorozoxozone Clorozoxozone Analgesics 250 mg PO BD

8. CRITICAL EVALUATION OF THE
PRESCRIPTION
QUESTIONNAIRE YES NO
Needing pharmacotherapy and not receiving it - 🗸
Taking or receiving the wrong drug - 🗸
Taking or receiving too little of the drug content - 🗸
Experiencing drug - drug interactions 🗸 -
Not taking or receiving the prescribed drug - 🗸
Taking or receiving a drug for no valid indication - 🗸

9. GOAL OF THERAPY:
 The main goal of anti-hypertensive drug is to treat or prevent CVS damage
 The goal is to reduce high BP and protect vital organs
DRUG INTERACTION:
 CLOPIDOGREL + PANTOPRAZOLE
 Serum concentration of active metabolites of Clopidogrel can be reduced when Clopidogrel is used in
combination with pantoprazole resulting in loss in efficiency
 HEPARIN + ACECLOFENAC
 Aceclofneac increases the anti coagulant activity of heparin, but the frequency of both the drug changes. So
there is no drug drug interaction

10. PATIENT COUNSELLING
 Follow the medical advice
 Quit smoking & Consuming Alcohol
 Heat pads.
 Ice application.
 Acupuncture.
 Gentle stretching exercises.
 Avoidance of sports or activities that worsen the pain.
 Physiotherapy or chiropractic therapy to help loosen up the rib cage.